Genome-wide association study of rheumatoid arthritis by a score test based on wavelet transformation by Jiang, Renfang et al.
BMC Proceedings
Proceedings
Genome-wide association study of rheumatoid arthritis
by a score test based on wavelet transformation
Renfang Jiang, Jianping Dong* and Yilin Dai
Address: Department of Mathematical Sciences, Michigan Technological University, 1400 Townsend Drive, Houghton, MI 49931, USA
E-mail: Renfang Jiang - rjiang@mtu.edu; Jianping Dong* - jdong@mtu.edu; Yilin Dai - ydai@mtu.edu
*Corresponding author
from Genetic Analysis Workshop 16
St Louis, MO, USA 17-20 September 2009
Published: 15 December 2009
BMC Proceedings 2009, 3(Suppl 7):S8 doi: 10.1186/1753-6561-3-S7-S8
This article is available from: http://www.biomedcentral.com/1753-6561/3/S7/S8
© 2009 Jiang et al; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background: We have conducted a genome-wide association study on the Genetic Analysis
Workshop (GAW) 16 rheumatoid arthritis data using a multilocus score test based on wavelet
transform proposed recently by the authors. The wavelet-based test automatically adjusts for the
amount of noise suppressed from the data. The power of the test is also increased by using the
genetic information contained in the spatial ordering of single-nucleotide polymorphisms on a
chromosome.
Results: After adjusting for the effect of population stratification, the test identified some
previously discovered rheumatoid arthritis susceptibility loci (HLA-DRB1 and rs3761847) as well as
some loci (rs2076530 and rs3130340) known to have association with sarcoidosis and bone
mineral density. It was previously reported that patients with rheumatoid arthritis have elevated
prevalence of sarcoidosis and have reduced bone mass.
Conclusion: This new test provides a useful tool in genome-wide association studies.
Background
In genome-wide association studies, the first choice of
tests is usually a single-marker test. If a single-nucleotide
polymorphism (SNP) has a strong association with a
disease, single-marker tests should have higher power
than multilocus tests. Multilocus tests can achieve higher
power if several SNPs are associated with the disease.
However, the potential high power of multilocus tests
could be diminished as an increased number of markers
results in an increased number of degrees of freedom.
Therefore, reducing the number of degrees of freedom is
essential to increasing the power of multilocus tests.
Different strategies were introduced to reduce the
number of degrees of freedom. Tests based on haplotype
sharing (the longest continuous interval of matching
alleles between haplotypes) effectively reduce the num-
ber of degrees of freedom [1,2]. Another popular
approach is to apply principal components analysis
(PCReg) [3]. A score test based on the Fourier transform
[4] is another attempt to reduce the degree of freedom,
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Open Accessthereby increasing power. Instead of using the genotype
data, weighted Fourier transform coefficients of the
genotype data are used to form a score test.
Many multilocus association tests are not affected by
permuting spatial order of SNPs; thus, they do not use
the information contained in the ordering of SNPs. For
example, the results of logistic regression will not change
i ft h eo r d e ro fS N P sa r ep e r m u t e d .T h es a m ei st r u ef o r
the test obtained by fitting a regression function with
one SNP followed by Bonferroni correction to find the
global p-value. PCReg is also invariant under the
permutation of SNPs. We provide a proof of the above
claims as follows (See Wang and Abbott [3] for notations
in the following proof.). Let G be a matrix of coded
genotypes and suppose it is centered. The variance-
covariance matrix of genotypes is A = G
TG/(n -1 )=
VDV
-1,w h e r eD is a diagonal matrix with eigenvalues of
A as diagonal entries, and the columns of V are the
eigenvectors. The regression model is y = GV1b + ε,w h e r e
V1 is the first several columns of V. After permutation of
SNPs, the columns of G are also permuted, and G
becomes GP, where P is a permutation matrix. Since
(GP)
T (GP)=( P
TV) D(P
TV)
-1, the eigenvalues are not
changed by the permutation, and the matrix of
eigenvectors becomes P
TV. The regression model
yG P P V b G V b =+ = +
T
11 εε remains unchanged. For
the tests based on shared haplotype length, changing
the ordering of SNPs could mean a shortened shared
length, and the association between the disease and the
SNPs could disappear. Therefore, the ordering of SNPs
contains important genetic information, and ignoring it
could lower the power of association tests.
We recently proposed a score test based on wavelet
transform [5,6], which is used in this report. This test has
three advantages. First, it uses the wavelet transformation
of genotype data instead of the genotype data. The
wavelet transform is designed to handle unsmooth noisy
signals. Genetic data are usually unsmooth and can be
dealt with by the wavelet transform naturally. Second, it
uses an empirical Bayes thresholding [7]. It was proved
by Johnston and Silverman that this thresholding
effectively suppresses noise from data [7]. Therefore, it
increases the power of the test. The exact amount of
noise being reduced depends on the specific problem.
Third, because our method views multilocus genotypes
of an individual as a discretized function, the spatial
ordering of the SNPs on a chromosome is taken into
consideration, which increases the power of the test.
Methods
There is a total of 2,062 individuals consisting of 868
cases and 1,194 controls in the North American
Rheumatoid Arthritis Consortium (NARAC) data for
Genetic Analysis Workshop (GAW) 16. These individuals
were genotyped on the 550 k Illumina SNP chip. We
analyzed 22 autosomal chromosomes in this report.
SNPs satisfying one of the following criterion were
excluded: missing genotype rate >0.05, or minor allele
frequency < 0.05, or having p-values < 0.00001 in the
Hardy-Weinberg equilibrium test. About 12.8% of SNPs
were removed. Missing genotypes were imputed by
fastPHASE [8]. We adopted a strategy of a moving
window of eight SNPs without overlapping (the first
window contains SNPs 1-8, the next window contains
SNPs 9-16, etc.) on the chromosome. We have tried
windows of sizes 16 and 32 SNPs and there was not
much difference. Overlapping windows were also tried
and again, the results were similar. Computational
burden increases when large windows or overlapping
windows were used. The k
th window is from the
(8(k - 1 )+1 )
th SNP to the 8k
th SNPs. Let Gk be the
corresponding eight columns of the genotype matrix G.
Different ways of coding SNPs do make a difference. The
SNPs in Gk were recoded to maximize the number of
positive pairwise correlations. This removes any ambi-
guity in the coding of genotypes. In our simulation
studies, the recoding increased the power of the test
while keeping the type I error rate in check.
We applied EIGENSTRAT [9] to remove the effects of
population stratification. T h et o pt h r e ee i g e n v e c t o r s
obtained by EIGENSTRAT were used to adjust genotypes
and phenotypes as suggested by Price et al. [9]. Let G be
t h eg e n o t y p em a t r i x ,C be the matrix of the principal
component vectors, and Y be the vector of phenotypes.
The adjusted genotype matrix is  G = G - CC
TG and the
adjusted phenotype vector is  Y = Y - CC
TY.B e f o r et h e
adjustment, the inflation factor [10] lGC =1 . 3 9 9 ,w h i c h
reduced to 1.025 after the adjustment. To avoid a
possible bias, all chromosomes except 6 and 8 were
included to produce the eigenvectors, which were used
to adjust genotypes on chromosomes other than 6.
Chromosome 6 was used to produce eigenvectors to
adjust genotypes on chromosome 6.
Consider the k
th window and the corresponding matrix
of adjusted genotype  Gk . Applying wavelet transform,
thresholding, and inverse wavelet transform consecu-
tively on the i
th row of  Gk resulted in the modified
genotype (xi1, xi2,. . . ,xim)o ft h ei
th individual. Subtract
the mean of the j
th column of X =( xij)f r o mxij such that
t h em e a no fe a c hc o l u m no fX =0 .L e t  Y =( y1, y2,. . . ,yn)
be the adjusted phenotype of n individuals. Assume a
generalized linear model [11] f(E(yi)) = a + Xib between
X and Y,w h e r ef is a link function. Let Uy x ji i j i
n
=
= ∑ 1 be
the score statistic for the markers. The variance of Uj
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2 2 The global score sta-
tistic of this window is TU V jj =∑∑ / .
The global p-values of the wavelet-based test were
obtained as follows. We randomly permuted the
phenotypes (case-control status) 5,000 times, and
received 5,000 sets of permuted phenotypes. Adjust
each set with the principal component vectors, and they
are still called permuted phenotypes. At each window of
e i g h tS N P s ,t h ev a l u eo fT was calculated 5,001 times,
using the adjusted phenotypes and 5,000 sets of
permuted phenotypes, respectively. In M windows
along the chromosomes, we have 5000 M values of T
with permuted phenotypes, denoted by a 5,000 × M
matrix (Tij), where Tij is the absolute value of T at the j
th
window using the i
th s e to fp e r m u t e dp h e n o t y p e s .L e t
mi =m a x j Tij be the maximum absolute value of T at M
windows using the i
th set of permuted phenotypes. Let Tj
be the absolute value of T at the j
th window using the
adjusted phenotypes. The global p-value of the wavelet-
b a s e dt e s ta tt h ej
th window is the proportion of mi > Tj:
global p-value of Tj =# { mi|mi > Tj}/5,000.
Results and discussion
After correcting for population stratification, significant
signals were only found on chromosomes 6 and 9. Four
windows on chromosome 6 attracted our attention. The
first window (rs9268005, rs3130340, rs3115553,
rs9268132, rs926070, rs6935269, rs7775397,
rs17422797) contains rs3130340, which was identified
to have association with bone mineral density and
fractures [12]. It has been reported that a large
proportion of men with rheumatoid arthritis (RA) had
reduced bone mass [13]. The p-value at this window is
0.0074. The second window (rs4424066, rs12529049,
rs3117099, rs3117098, rs3817973, rs1980493,
rs2076530, rs4248166) contains rs2076530, which is
associated with sarcoidosis [14]. Increased prevalence of
sarcoidosis among RA patients has been reported [15].
The association between sarcoidosis, RA, and rs2076530
is an interesting phenomenon. The association between
rs2076530 and RA was investigated before, but whether
it is a causal SNP for RA or its effect is merely a carryover
effect of nearby haplotypes [16] merits further investiga-
tion. The third window (rs2395182, rs3129890,
rs9268832, rs6903608, rs2395185, rs477515,
rs2516049, rs2858870) contains HLA-DRB1,w h i c hh a s
long been identified as a major genetic risk contributor
to RA [17]. The last window (rs9275224, rs5000634,
rs6457617, rs2647012, rs9357152, rs10484561,
rs9275313, rs1794282) contains rs6457617, which has
also been reported as being associated with RA [18]. The
p-values of the test at the above three windows are less
than 0.0002 (it is 0 after 5,000 permutations). The most
significant window on chromosome 9 (rs1953126,
rs10985073, rs3761847, rs10985095, rs10985097,
rs2900180, rs12235400, rs10985112) which contains
rs3761847 and it was identified as a risk locus for RA
[19], has a p-value 0.53.
We applied the wavelet-based test on a moving window
of eight SNPs with overlapping (the first window
contains SNPs 1-8, the second window contains SNPs
2-9, etc.) on a 550-kb region of chromosome 6 for fine
mapping. The results are shown in Figure 1. We have
tried other window sizes (16 and 32) and found similar
results (not shown). Comparisons of the wavelet-based
test using overlapping and non-overlapping windows
showed no significant differences. In Figure 2, we
compared the wavelet-based test with Armitage c
2 test.
If p-value of the wavelet-based test is 0 after 5,000
permutations, we set the p-value as 0.0002 in order to
calculate log(p-value) in Figures 1 and 2, which makes
0.0002 the smallest possible p-value in this study. Some
significant loci (HLA-DRB1, rs2076530, rs6457617)
were identified by both tests. However, the Armitage c
2
test was not significant around rs3130340 (p-value after
Bonferroni correction was 1), while the p-value of the
wavelet-based test at the window containing the SNP
was 0.0074, after correcting for multiple testing.
Conclusion
A wavelet-based multilocus score test was applied in a
genome-wide association study on RA data followed by
fine mapping of regions identified in our genome-wide
association study. Several statistically significant risk loci
for RA were identified after adjustment for population
stratification. Some windows contain genes and/or SNPs
(HLA-DRB1, rs3761847, and rs6457617) previously
associated with RA. Some windows contain SNPs
(rs2076530, rs3130340) previously associated with
sarcoidosis [14] or bone mineral density and fractures
[12], all of which have been reported as being related
with RA [13,15].
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Figure 1
p-Values on 22 chromosomes, and comparison of windows. The plot on the left contains the p-values of
the wavelet-based test on 22 chromosomes. The horizontal line indicates 5% significance level. The plots on the right
are a comparison of overlapping windows (top) and non-overlapping windows (bottom) for a 550-kb region
on chromosome 6.
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